Skip to main content
Caplight Logo









Mage Biologics Inc.

Mage Biologics Inc.

Private
Newark, DelawareHealthcare & Life Scienceshttps://magebiologics.com

Last Round

Corporate Funding

Jul 20, 2023

Total Funding Raised

$28M

Company Overview

Mage Biologics Inc. operates in Healthcare & Life Sciences and is based in Newark, Delaware. Its latest recorded funding round was a Corporate Funding round in July 2023.

Mage Biologics Inc. is a biotechnology company that develops orally administered monoclonal antibodies for the treatment of inflammatory bowel diseases such as ulcerative colitis.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Mage Biologics Inc. Comparables

Compare Mage Biologics Inc. with similar companies based on industry and business-model similarity.

Mage Biologics Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sorriso Therapeutics
84%
Rafael Holdings, Inc.
74%
Bristol Myers Squibb
72%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Mage Biologics Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingJul 20, 2023
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Mage Biologics Inc. Investors

Notable investors and investment history

Mage Biologics Inc. investors
InvestorRounds
TVM CapitalCorporate Funding

Mage Biologics Inc. Filings

Explore SEC and related filing metadata, where available.

Mage Biologics Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Mage Biologics Inc.'s valuation, stock price, and market status.

Is Mage Biologics Inc. a public or private company?

Mage Biologics Inc. is a private company.

What is the current stock price of Mage Biologics Inc.?

Mage Biologics Inc. is a private company, so its shares have no public market price. Caplight tracks Mage Biologics Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Mage Biologics Inc. worth (valuation)?

Valuation information for Mage Biologics Inc. is not publicly available.

Can I buy Mage Biologics Inc. stock?

Mage Biologics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Mage Biologics Inc.'s last funding round?

Mage Biologics Inc.'s most recent funding round was Corporate Funding on July 20, 2023.

Who are the main investors in Mage Biologics Inc.?

Key investors in Mage Biologics Inc. include TVM Capital.

Will Mage Biologics Inc. IPO soon?

No public IPO plans have been announced for Mage Biologics Inc..

How can I track Mage Biologics Inc. secondary market activity?

Caplight tracks bids, offers, and trades in Mage Biologics Inc.'s shares on secondary markets.

Firmographic Details

HeadquartersNewark, Delaware
Year Founded2023
Last FundingJul 20, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?